← Leaderboards
Swey-Shen Chen
Institute Of Genetics
$7,400,174
Attributed
$7,935,963
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,935,963 · 8
By mechanism
R44$4,868,465 · 2
R43$2,816,892 · 5
R21$250,606 · 1
Top collaborators
- Daniel K Hsu2 shared
- Fu-Tong Liu2 shared
Others in their field
Top investigators on “Mast Cell”
- Joshua A Boyce · Brigham And Women'S Hospital$37,449,879
- Ehud Isacoff · University Of California Berkeley$23,946,000
- Stephen J Galli · Stanford University$21,015,245
- Wanda Phipatanakul · Boston Children'S Hospital$17,532,452
- Sally E Wenzel · University Of Colorado Denver$16,893,979
- Gloria David · Rho Federal Systems Division, Inc.$15,843,849
Research focus
Mast CellInflammatorySafetyMediatingHypersensitivityAffinityCellsResponseAllergensImmunogenicityExtrinsic AsthmaIn VivoXolairLungIn VitroAllergicImmunizationAnaphylaxisAmino Acid SequenceCostBaseExhibitsDendritic CellsAntibodies
Grant awards (16)
Protein display drug ANDI reduces asthmatic airway hyperreactivity$320,863
R43 · FY2025 · AI · contact PI
Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma$982,439
R44 · FY2019 · AI · contact PI
Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma$813,544
R44 · FY2018 · AI · contact PI
CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma$549,186
R44 · FY2018 · AI · contact PI
CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma$856,276
R44 · FY2017 · AI · contact PI
Broadly neutralizing(BN) pan-IgE supersite vaccine for allergic asthma$813,544
R44 · FY2017 · AI · contact PI
CTL for supertype natural IgE cytotoxic peptide (nECP) to guard against allergic asthma$853,476
R44 · FY2016 · AI · contact PI
Targeting Galectin-3 with novel drugs for treatment of eczema$402,036
R43 · FY2010 · AI · contact PI
Bi-functional Therapeutics for Allergy-BFTA$300,000
R43 · FY2010 · AI · contact PI
Targeting Galectin-3 with novel drugs for treatment of eczema$401,647
R43 · FY2009 · AI · contact PI
Bi-functional Therapeutics for Allergy-BFTA$300,000
R43 · FY2009 · AI · contact PI
Allergy Protection by Active IgE B Cell Vaccines$299,854
R43 · FY2004 · AI
Allergy Protection by Active IgE B Cell Vaccines$253,092
R43 · FY2003 · AI
Allergy Prevention By lgE Cytotoxic Peptide(ECP)Vaccine$307,200
R43 · FY2002 · AI
IMMUNIZATION WITH ANTIGENIZED VECTORS$250,606
R21 · FY2001 · AI
Allergy Prevention By lgE Cytotoxic Peptide(ECP)Vaccine$232,200
R43 · FY2001 · AI